ORO VALLEY, AZ (January 12, 2024) -- Ventana Medical Systems, Inc., owned by Roche Tissue Diagnostics, purchased the Pharmaceutical R&D Facility at 2090 E Innovation Park Dr. for $25 million ($222 PSF). The 112,500-square-foot facility on 11.54 acres was previously Icagen’s ultra-high-throughput biology, screening, and chemistry research facility after Icagen bought Sanofi in 2016.
Roche Holding AG merged with Ventana Medical Systems in 2008 and is located adjacent to the former Icagen building, which has been vacant since 2020. Ventana purchased to occupy for expansion.
The total project cost for building construction, including acquisition, construction, and improvement, totaled over $90 million, or $803 PSF. Given today‘s construction costs and the required time to replicate the facility in today’s market, it could arguably take 3-4 years to construct and cost well over $1,000 per square foot for the building alone.
The two-story building and a basement were constructed as a drug discovery research lab with 78,981 square feet of laboratory and 12,550 square feet of office space. The atrium, conference, and support areas on all three levels total 20,969 square feet. The power is 13,800 AMP, 480 volts, with a 1,500 kW generator and base fuel tank serving critical loads. VAV, 100% single pass air, with two 600-ton Chill Paks. The building is LEED Gold Certified with solar-heated water, laboratory air heat exchangers, and office area convection temperature control.
Ventana Medical, today known as Roche Tissue Diagnostics, has revolutionized cancer diagnostics worldwide through state-of-the-art testing automation. It provides more than 250 cancer tests and associated instruments, making it the leading global supplier of cancer diagnostic systems to the pathology market. They also improve patient care through tests determining which patients are most likely to benefit from specific therapies. Companion diagnostics link the most accurate diagnosis with the most targets and relevant therapeutic available for each patient.
The transaction closed on December 15, 2023.
Tim Healy with CBRE Tucson handled the transaction for Roche.
To learn more, see RED Comp #11035.